peptide garden

Understand peptides.
Make informed decisions.

Independent, evidence-based profiles of every peptide that matters. No vendors. No hype. Just honest science, clearly explained.

Detailed peptide profilesEvery claim cited
Peptide profiles

Explore featured peptides

Each profile is independently researched. Evidence bars show the strength of current scientific support.

BPC-157

Research compound

A peptide fragment studied for tissue repair, gut healing, and recovery. Most evidence is preclinical.

Gut health
Tissue repair
Human trials

Animal studies are promising, but human clinical data is very limited.

Read full profile →

GHK-Cu

Available topically

A copper peptide naturally found in your body. Studied for skin health, wound healing, and anti-aging effects.

Skin repair
Wound healing
Human trials

One of the better-studied peptides for topical skin care.

Read full profile →

Thymosin Alpha-1

Available with prescription

An immune-modulating peptide approved in 30+ countries for chronic infections and immune support.

Immune support
Clinical use
Human trials

Solid clinical track record internationally.

Read full profile →

Semaglutide

FDA-approved

A GLP-1 receptor agonist FDA-approved for type 2 diabetes and weight management.

Weight mgmt
Glucose control
Human trials

Extensive clinical evidence. Widely prescribed and studied.

Read full profile →
Peptide profile

BPC-157

Body Protection Compound-157 — a synthetic pentadecapeptide derived from a protective protein in human gastric juice. Studied primarily for tissue repair and gut healing.

At a glance

BPC-157 is one of the most talked-about peptides in the recovery space. It shows real promise in animal studies for healing tendons, ligaments, muscle, and gut tissue. However, published human clinical trials are very limited — we're still waiting for the data that would tell us how well it truly works in people.

Animal studiesStrong47 studies

Consistent results across 12 animal models including rats, mice, and horses. Strongest evidence for tendon and GI repair.

Human evidenceMinimal3 trials

Only 3 small human studies (~30 total participants). No completed Phase III trial. First rigorous RCT began recruiting February 2026.

Safety dataLimited2 subjects

Total controlled human safety data from exactly 2 subjects. Low toxicity in animals, but long-term human safety is unknown.

BPC-157 has promising animal data for tissue repair, but human clinical trials are very limited. Here's what that means: the biological mechanism is plausible and early signals are encouraging, but we can't yet say with confidence how it performs in humans at specific doses.
Despite more than one hundred animal studies demonstrating healing effects across multiple organ systems, BPC-157 has never completed a human clinical trial — the most significant gap in its evidence profile.
Peptide Garden evidence assessment, March 2026

What it does

BPC-157 is believed to promote healing through several mechanisms: stimulating growth factor expression, promoting blood vessel formation (angiogenesis), and modulating the nitric oxide system. In animal models, it has accelerated recovery from cuts, burns, tendon injuries, and some neurological damage.

The peptide appears to have a protective effect on the GI tract, which is why it's sometimes called “body protection compound.” Researchers have studied it for conditions ranging from inflammatory bowel issues to NSAID-induced stomach damage.

How people use it

BPC-157 is most commonly discussed in the context of injury recovery and gut health. Some practitioners offer it as a subcutaneous injection, while others explore oral capsules. It is not currently FDA-approved for any condition.

Dosing information circulating online varies widely and should be treated with caution. If you're considering BPC-157, a conversation with a knowledgeable healthcare provider is a good starting point.

Safety & side effects

In animal studies, BPC-157 has shown a remarkably low toxicity profile with no reported lethal dose. However, the absence of robust human safety data means we should be cautious about drawing firm conclusions.

Reported side effects in user communities are generally mild (injection-site irritation, occasional nausea), but these are self-reported and not from controlled studies. Long-term safety in humans is unknown.


Evidence comparison

BPC-157 vs Semaglutide

BPC-157

Research compound · Not FDA-approved

Animal evidence82%
Human evidence12%
Safety data18%

Total studies

~100+

Human trials

3

FDA status

Category 2

First studied

1991

Semaglutide

FDA-approved · 3 brand names

Animal evidence90%
Human evidence95%
Safety data92%

Total studies

1,000+

Human trials

100+

FDA status

Approved

First studied

2012